Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 181 AL 195

A Comprehensive Review on the Benefits and Problems of Curcumin with Respect to Human Health

Liu S, Liu J, He L, Liu L, Cheng B, Zhou F, Cao D, He Y.

Molecules. 2022 Jul 8;27(14):4400. doi: 10.3390/molecules27144400.

The Monkey Head Mushroom and Memory Enhancement in Alzheimer's Disease

Yanshree, Yu WS, Fung ML, Lee CW, Lim LW, Wong KH.

Cells. 2022 Jul 24;11(15):2284. doi: 10.3390/cells11152284.

Update on new trend and progress of the mechanism of polysaccharides in the intervention of Alzheimer's disease, based on the new understanding of relevant theories: A review

Zhang X, Lin L, Li H, Xia W, Liu Q, Zhou X, Dong L, Fu X.

Int J Biol Macromol. 2022 Oct 1;218:720-738. doi: 10.1016/j.ijbiomac.2022.07.158. Epub 2022 Jul 25.

Therapeutic Potential of Different Natural Products for the Treatment of Alzheimer's Disease

Chakraborty B, Mukerjee N, Maitra S, Zehravi M, Mukherjee D, Ghosh A, Massoud EES, Rahman MH.

Oxid Med Cell Longev. 2022 Jul 22;2022:6873874. doi: 10.1155/2022/6873874. eCollection 2022.

Delineating biosynthesis of Huperzine A, A plant-derived medicine for the treatment of Alzheimer's disease

Li X, Li W, Tian P, Tan T.

Biotechnol Adv. 2022 Nov;60:108026. doi: 10.1016/j.biotechadv.2022.108026. Epub 2022 Jul 30.

Kaempferol as a potential neuroprotector in Alzheimer's disease

Nejabati HR, Roshangar L.

J Food Biochem. 2022 Dec;46(12):e14375. doi: 10.1111/jfbc.14375. Epub 2022 Aug 5.

Dendrimers: A Neuroprotective Lead in Alzheimer Disease: A Review on its Synthetic approach and Applications

Singh A, Ansari VA, Mahmood T, Ahsan F, Wasim R.

Drug Res (Stuttg). 2022 Oct;72(8):417-423. doi: 10.1055/a-1886-3208. Epub 2022 Aug 5.

Alzheimer's disease failed clinical trials

Asher S, Priefer R.

Life Sci. 2022 Oct 1;306:120861. doi: 10.1016/j.lfs.2022.120861. Epub 2022 Aug 4.

The glymphatic system: implications for drugs for central nervous system diseases

Lohela TJ, Lilius TO, Nedergaard M.

Nat Rev Drug Discov. 2022 Oct;21(10):763-779. doi: 10.1038/s41573-022-00500-9. Epub 2022 Aug 10.

Forest Biomass as a Promising Source of Bioactive Essential Oil and Phenolic Compounds for Alzheimer's Disease Therapy

Moreira P, Matos P, Figueirinha A, Salgueiro L, Batista MT, Branco PC, Cruz MT, Pereira CF.

Int J Mol Sci. 2022 Aug 8;23(15):8812. doi: 10.3390/ijms23158812.

Advances on Therapeutic Strategies for Alzheimer's Disease: From Medicinal Plant to Nanotechnology

Hassan NA, Alshamari AK, Hassan AA, Elharrif MG, Alhajri AM, Sattam M, Khattab RR.

Molecules. 2022 Jul 28;27(15):4839. doi: 10.3390/molecules27154839.

Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer's disease

Wang Z, Weaver DF.

Int Immunopharmacol. 2022 Sep;110:109070. doi: 10.1016/j.intimp.2022.109070. Epub 2022 Jul 21.

Medicine-food herb: Angelica sinensis, a potential therapeutic hope for Alzheimer's disease and related complications

Long Y, Li D, Yu S, Shi A, Deng J, Wen J, Li XQ, Ma Y, Zhang YL, Liu SY, Wan JY, Li N, Yang M, Han L.

Food Funct. 2022 Aug 30;13(17):8783-8803. doi: 10.1039/d2fo01287a.

Deciphering the enigmatic crosstalk between prostate cancer and Alzheimer's disease: A current update on molecular mechanisms and combination therapy

Poddar NK, Agarwal D, Agrawal Y, Wijayasinghe YS, Mukherjee A, Khan S.

Biochim Biophys Acta Mol Basis Dis. 2022 Nov 1;1868(11):166524. doi: 10.1016/j.bbadis.2022.166524. Epub 2022 Aug 17.

Personalized Prediction of Alzheimer's Disease and Its Treatment Effects by Donepezil: An Individual Participant Data Meta-Analysis of Eight Randomized Controlled Trials

Yoshida K, Seo M, Luo Y, Sahker E, Cipriani A, Leucht S, Iwatsubo T, Efthimiou O, Furukawa TA.

J Alzheimers Dis. 2022;89(4):1143-1157. doi: 10.3233/JAD-220263.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias